InvestorsHub Logo
Followers 53
Posts 1789
Boards Moderated 0
Alias Born 03/22/2015

Re: Drugdoctor post# 305959

Tuesday, 12/11/2018 6:35:08 AM

Tuesday, December 11, 2018 6:35:08 AM

Post# of 404141
Another interesting point about those lists...




https://www.lowestmed.com/top-100-drugs-lists/




Not only does ELTP own ANDA's for the top 3 drugs filled without insurance coverage, but also amlodipine is in the top 10 on both lists. I have a buttload of patients who take amlodipine for blood pressure, and if STEADYPD-III is positive, I will change a goodly number of those scripts to isradipine. I love using generic drugs that have multiple benefits, and in the next few months, we will hear if isradipine fits that description. Why would I continue to prescribe a calcium channel blocker that only decreases blood pressure when I could prescribe a different calcium channel blocker that lowers BP and also protects against neurological damage? The STEADY results are all I'm waiting for, and as soon as positive results are available, I will start prescribing it. I will not need to wait for FDA to say anything about it. I'll just start prescribing isradipine instead of amlodipine for BP, and I bet a lot of PCP's will eventually be doing the exact same thing.








Call on God but row away from the rocks.

-Hunter S. Thompson

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News